What the company does
Nanexa AB (publ), a pharmaceutical company, develops injectable drug products in the Nordic countries, Europe, Asia, and North America. The company offers PharmaShell, a drug delivery system based on atomic layer deposition coating technology for controlled release of various types of active pharmaceutical substances. It also develops NEX-22, a glucagon-like peptide-1 analogue liraglutide that has completed Phase I trial for the treatment of type 2 diabetes; NEX-18, a drug from azacitidine to treat myelodysplastic syndrome; and NEX-20, a drug from lenalidomide for the treatment of multiple myeloma. The company has collaborations with Novo Nordisk to …
What the weekly tape is saying
NANEXA closed the latest completed week at 4.46 SEK. The 4-week return is 21.2% and the 12-week return is 14.5%. Trend Signal is active, Market Dynamics is 0.08. Setup signature: Leadership continuation with a 72/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 3.60 SEK
- Vs Trend Line
- 24.1%
- Fair Value
- 2.03 SEK
- Vs Fair Value
- 119.5%
- 52W High
- 5.00 SEK
- 52W Low
- 1.40 SEK
- Drawdown
- -10.7%
- Range Position
- 85.1%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 25 weeks
- 52W Active Weeks
- 42
- 52W Active Breadth
- 80.8%
- Sector Scope
- SE Healthcare
- Sector Rank
- 37 of 158
- Sector Percentile
- 77.1%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
SE Healthcare
- Tracked Peers
- 100
- 4W Rank
- 5 of 100
- Avg 1W
- 2.8%
- Avg 4W
- 1.2%
- Trend Breadth
- 29.0%
- Positive MD
- 69.0%
SE Drug Manufacturers - Specialty & Generic
- Tracked Peers
- 19
- 4W Rank
- 5 of 19
- Avg 1W
- 3.4%
- Avg 4W
- 5.3%
- Trend Breadth
- 36.8%
- Positive RS
- 26.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.08
- 4W MD Change
- 112.6%
- Relative Strength
- 38.97
- 4W RS Change
- 78.4%
- Expectation
- Undecided
- Probability
- 46.72%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 1.9M
- 13W Average
- 2.7M
- 52W Average
- 3.6M
- Vs 13W
- 0.7x
- Vs 52W
- 0.5x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.1%
- 52W Volatility
- 11.8%
- Upside Weeks
- 29
- Downside Weeks
- 23
- Downside Breadth
- 44.2%
- Avg Gain / Loss
- 7.9% / -5.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- STO
- Country
- SE
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Currency
- SEK
- Market Cap
- 831.5M
Opportunity signals
- Trend Signal is active with a 25-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 4.46 SEK | 4.1% | 3.60 SEK | 2.03 SEK | 0.08 | 38.97 | 1.9M | On |
| 5 Jun 2026 | 4.29 SEK | 0.4% | 3.51 SEK | 2.03 SEK | -0.20 | 34.64 | 2.4M | On |
| 29 May 2026 | 4.28 SEK | 18.4% | 3.42 SEK | 2.02 SEK | -0.45 | 34.62 | 3.5M | On |
| 22 May 2026 | 3.61 SEK | -2.0% | 3.34 SEK | 2.02 SEK | -0.73 | 14.58 | 1.9M | On |
| 15 May 2026 | 3.69 SEK | 2.2% | 3.29 SEK | 2.01 SEK | -0.64 | 21.84 | 1.9M | On |
| 8 May 2026 | 3.60 SEK | 5.1% | 3.23 SEK | 2.01 SEK | -0.58 | 18.80 | 2.2M | On |
| 1 May 2026 | 3.43 SEK | -7.4% | 3.18 SEK | 2.01 SEK | -0.54 | 14.01 | 4.0M | On |
| 24 Apr 2026 | 3.71 SEK | -2.5% | 3.14 SEK | 2.01 SEK | -0.57 | 22.61 | 2.3M | On |
| 17 Apr 2026 | 3.80 SEK | -2.6% | 3.09 SEK | 2.01 SEK | -0.56 | 24.02 | 3.5M | On |
| 10 Apr 2026 | 3.90 SEK | 4.6% | 3.03 SEK | 2.01 SEK | -0.50 | 31.81 | 2.4M | On |
| 3 Apr 2026 | 3.73 SEK | 0.8% | 2.98 SEK | 2.01 SEK | -0.36 | 34.05 | 1.6M | On |
| 27 Mar 2026 | 3.70 SEK | -5.1% | 2.94 SEK | 2.01 SEK | -0.06 | 40.02 | 4.1M | On |
| 20 Mar 2026 | 3.90 SEK | 1.6% | 2.89 SEK | 2.01 SEK | 0.18 | 50.18 | 3.4M | On |
| 13 Mar 2026 | 3.84 SEK | -2.7% | 2.83 SEK | 2.01 SEK | 0.38 | 43.14 | 2.4M | On |